As omics research expands in scale and complexity, advances in mass spectrometry are helping scientists generate deeper, more reliable insights across proteomics, lipidomics, and metabolomics.
By adopting Simplicis Ledger, Flare Therapeutics replaces manual "human-babysitting" of data with automation-ready infrastructure to scale life sciences R&D.
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability
Discover practical strategies to improve pipetting accuracy, reproducibility, ergonomics, and instrument performance across diverse laboratory workflows.